IRF4 and diffuse large B-cell lymphoma: In addition, Nyman et al.[38] used FOXP1 and MUM1/IRF4 as activated B-cell-like markers to distinguish patients between the activated B-cell-like and other diffuse large B-cell lymphoma subtypes.